Employer profile
21medtech
4 certified H-1B filings across 2 fiscal years.
FY2022 filings
1
FY2022 median
$94k
Top role
Director Of Regulatory And Quality Affairs
1 filings
Top state
NC
4 filings
21medtech has filed 4 certified H-1B Labor Condition Applications over FY2021–FY2022. In FY2022, its median certified base salary was $94k ($94k–$94k interquartile range). The most-filed role is Director Of Regulatory And Quality Affairs (1 filings).
Year-over-year
How 21medtech hired across H-1B fiscal years. YoY column compares to the prior FY.
| FY | Filings | Median $ | YoY % |
|---|---|---|---|
| FY2022 | 1 | $94k | -67 |
| FY2021 | 3 | $95k | — |
Top job titles
Most-filed positions, across all years (raw DOL titles).
| Job Title | Filings | Median |
|---|---|---|
| Director Of Regulatory And Quality Affairs | 1 | $94k |
Top worksite states
Where this employer files.
| State | Filings | Median |
|---|---|---|
| NC | 4 | $94k |
Prevailing wage level distribution
DOL Levels I–IV approximate experience tiers (I = entry, IV = fully competent). A heavy Level I/II skew suggests entry-level / contractor-style hiring; a heavy IV skew suggests senior in-house roles.
Lvl I
125%
Lvl III
125%
Lvl IV
250%
Frequently asked questions
- Does 21medtech sponsor H-1B visas?
- Yes. 21medtech has filed 4 certified H-1B Labor Condition Applications (LCAs) over FY2021–FY2022. An LCA is a required step before an employer files an H-1B petition; a certified LCA does not by itself guarantee an approved visa.
- What is the median H-1B salary at 21medtech?
- In FY2022, the median certified H-1B base salary at 21medtech was $94k, with a 25th–75th percentile range of $94k–$94k. This is the annual base wage stated on the LCA and excludes bonus, equity, and other compensation.
- What jobs does 21medtech hire H-1B workers for?
- 21medtech's most-filed H-1B role is Director Of Regulatory And Quality Affairs (1 filings). Its top worksite state is NC.
- How many H-1B filings did 21medtech submit in FY2022?
- 21medtech had 1 certified H-1B LCA filings in FY2022 — a 67% decrease from the prior fiscal year.